RxDoctor Payments Data

Sharon Frey

Infectious Disease · Saint Louis, MONPI 1356359228

Payments from drug & device makers

What this record shows

This record is dominated by education: $189 of the $213 with a category attached, or 88.7%. 3 manufacturers reported payments, led by Astellas Pharma US Inc at 46.5% of the total. That places this record below the midpoint for infectious disease clinicians in MO, where the typical reported total is $219.

$213in general payments, 2019–2025

Across 3 payments — averaging $71.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$99
  • Seqirus USA Inc$90
  • Bavarian Nordic A/s$24
$702,083in research payments, 2019–2025

Across 39 payments — averaging $18,002 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$606K
  • Bavarian Nordic A/s$91K
  • Takeda Pharmaceuticals U.S.A., Inc.$5K

What the payments were for

  • Food & beverage$2411%
  • Education$18989%

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$213 in reported general payments places this provider in the 45th percentile of 177 infectious disease providers in Missouri.

See all infectious disease providers in Missouri →

Other infectious disease in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →